Literature DB >> 2994897

Prevention and control of herpesvirus diseases. Part 2. Epidemiology and immunology.

.   

Abstract

This is the second of two articles summarizing the information currently available on herpes virus diseases. The first described the different members of the herpesvirus group, clinical expression of infection, laboratory diagnosis, and chemotherapy. This article dealing with the epidemiological and immunological aspects of herpesvirus infections also brings up the special problems caused by virus latency and risks associated with congenital infection and immunodeficiency or immunodepressive treatment. The prospects of preventing herpesvirus infections by vaccination and treatment with immune sera are also discussed.

Entities:  

Mesh：

Year:  1985        PMID： 2994897      PMCID： PMC2536424     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  25 in total

1.  ELISA for herpes simplex virus (HSV) type-specific antibodies in human sera using HSV type 1 and type 2 polyspecific antigens blocked with type-heterologous rabbit antibodies.

Authors:  B F Vestergaard; P C Grauballe
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-08

2.  Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis.

Authors:  W P Glezen; G W Fernald; J A Lohr
Journal:  Am J Epidemiol       Date:  1975-02       Impact factor: 4.897

Review 3.  Live attenuated Varicella-Zoster vaccine.

Authors:  A A Gershon
Journal:  Rev Infect Dis       Date:  1980 May-Jun

4.  Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies.

Authors:  L Pereira; D V Dondero; D Gallo; V Devlin; J D Woodie
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

5.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.

Authors:  E De Clercq; J Descamps; G Verhelst; R T Walker; A S Jones; P F Torrence; D Shugar
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

6.  Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.

Authors:  A S Yeager; F C Grumet; E B Hafleigh; A M Arvin; J S Bradley; C G Prober
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

Review 7.  Cytomegalovirus infections following renal transplantation.

Authors:  J Glenn
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

8.  Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents.

Authors:  J A Embil; R G Stephens; F R Manuel
Journal:  Can Med Assoc J       Date:  1975-10-04       Impact factor: 8.262

9.  Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response.

Authors:  W C Reeves; L Corey; H G Adams; L A Vontver; K K Holmes
Journal:  N Engl J Med       Date:  1981-08-06       Impact factor: 91.245

10.  Direct immunofluorescence staining for detection of herpes simplex and varicella-zoster virus antigens in vesicular lesions and certain tissue specimens.

Authors:  N J Schmidt; D Gallo; V Devlin; J D Woodie; R W Emmons
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948
View more
  1 in total

1.  Prevalence of antibodies to herpes simplex virus type 1 in different population groups in Italy.

Authors:  E Franco; F Caprilli; L Zaratti; P Pasquini
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.